Designing molecules

Specific peptides for specific receptors

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegradation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure-biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin-agonist analogues with exceptional δ-opioid-receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ-opioid receptors.

Original languageEnglish (US)
JournalEpilepsia
Volume30
Issue numberSUPPL. 1
StatePublished - 1989

Fingerprint

Peptide Receptors
Opioid Receptors
Peptides
Opioid Peptides
Narcotic Antagonists
Enkephalins
Molecular Dynamics Simulation
Structure-Activity Relationship
Somatostatin
Central Nervous System

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Designing molecules : Specific peptides for specific receptors. / Hruby, Victor J.

In: Epilepsia, Vol. 30, No. SUPPL. 1, 1989.

Research output: Contribution to journalArticle

@article{2f96f9ccf8f94181b3d71170c4588fd8,
title = "Designing molecules: Specific peptides for specific receptors",
abstract = "Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegradation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure-biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin-agonist analogues with exceptional δ-opioid-receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ-opioid receptors.",
author = "Hruby, {Victor J}",
year = "1989",
language = "English (US)",
volume = "30",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Designing molecules

T2 - Specific peptides for specific receptors

AU - Hruby, Victor J

PY - 1989

Y1 - 1989

N2 - Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegradation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure-biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin-agonist analogues with exceptional δ-opioid-receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ-opioid receptors.

AB - Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegradation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure-biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin-agonist analogues with exceptional δ-opioid-receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ-opioid receptors.

UR - http://www.scopus.com/inward/record.url?scp=0024462585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024462585&partnerID=8YFLogxK

M3 - Article

VL - 30

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - SUPPL. 1

ER -